BD 1 Mouse

BD 1 Mouse
Shipped with Ice Packs
In Stock

Description

Introduction to Mouse Beta-Defensin 1 (BD-1)

Beta-Defensin 1 (BD-1) belongs to the defensin family, a group of highly conserved antimicrobial peptides that play essential roles in the innate immune system. In mice, BD-1 is a small cationic peptide that forms an important component of epithelial defense mechanisms. The protein is also known by several synonyms including: Beta-defensin 1, Defensin beta 1, DEFB1, DEFB101, and DEFB-1 .

As a member of the defensin family, Mouse BD-1, like its human counterpart, contributes significantly to antimicrobial defense at epithelial surfaces. These defensins are characterized by their cationic nature and conserved cysteine residues that form intramolecular disulfide bonds, critical for their antimicrobial activity .

Physical and Chemical Properties

PropertyValueReference
Molecular Mass4.1 kDa
Amino Acid Length37 residues
AppearanceWhite lyophilized powder (recombinant form)
SolubilityWater-soluble; recommended reconstitution at >100 μg/ml
Purity>97% by RP-HPLC and SDS-PAGE analysis
UniProt IDP56386
Gene ID13214

Recombinant Production and Purification

Recombinant Mouse BD-1 is typically produced in Escherichia coli expression systems. The production process yields a non-glycosylated polypeptide identical to the native sequence but produced in a controlled laboratory environment .

The purification of recombinant Mouse BD-1 involves proprietary chromatographic techniques to ensure high purity (typically >97%) . The purified protein is often lyophilized from a 0.2μm filtered concentrated solution in PBS at pH 7.4 for stability during storage and shipping .

Commercial preparations of BD-1 Mouse are available in various sizes, typically ranging from 5-20 μg for research purposes, with larger quantities (up to 1 mg) available for specialized applications . These preparations are suitable for various research applications, including studies on antimicrobial activity and immune response mechanisms.

Antimicrobial Activity

Mouse BD-1 functions primarily as an antimicrobial peptide that provides resistance at epithelial surfaces to microbial colonization . The peptide exhibits broad-spectrum antimicrobial activity against various pathogens, including bacteria, fungi, and some viruses.

The antimicrobial mechanism of BD-1 involves disruption of microbial cell membranes through electrostatic interactions between the cationic peptide and negatively charged microbial surfaces. This disruption leads to membrane permeabilization and eventual cell death of the microorganisms .

Immunomodulatory Functions

Beyond direct antimicrobial activity, Mouse BD-1 demonstrates important immunomodulatory functions. Research indicates it can act as a chemoattractant for CD34+ dendritic cells, with a specific activity range of 1,000-10,000 units/mg . This chemotactic activity potentially enhances adaptive immune responses by recruiting immune cells to sites of infection.

Role in Disease Pathogenesis

Emerging research suggests Beta-defensin 1 may play a significant role in the pathogenesis of severe sepsis . The protein has also been implicated in various inflammatory conditions due to its dual antimicrobial and immunomodulatory functions.

Studies in human systems have shown differential expression of Beta-Defensin-1 in certain disease states. For instance, patients with atopic dermatitis and mycosis fungoides show lower Beta Defensin-1 mRNA expression compared to Beta Defensin-2 and Beta Defensin-3 . While these findings are from human studies, they suggest potential parallel roles for mouse BD-1 in similar disease models.

Immunological Research

Mouse BD-1 is widely used in immunological research to study:

  • Innate immune mechanisms

  • Epithelial defense systems

  • Host-pathogen interactions

  • Inflammatory processes

Experimental Applications

ApplicationMethodPurposeReference
Chemotaxis AssaysCell migration assaysMeasure dendritic cell attraction
Antimicrobial TestingZone of inhibition assaysEvaluate antimicrobial potency
Western BlottingSDS-PAGEProtein detection and quantification
Flow CytometryImmunostainingCellular expression analysis-

Reconstitution Guidelines

For optimal results, it is recommended to reconstitute lyophilized Mouse BD-1 in sterile water (18MΩ-cm H₂O) at a concentration not less than 100 μg/ml . After initial reconstitution, the solution can be further diluted in appropriate buffers for experimental use.

For long-term storage of reconstituted protein, the addition of a carrier protein (0.1% HSA or BSA) is recommended to prevent loss of activity . Repeated freeze-thaw cycles should be avoided to maintain protein integrity and activity .

Comparative Analysis and Future Perspectives

Mouse BD-1 shares significant structural and functional homology with human Beta-Defensin 1, making it a valuable model for studying human immunological processes. The protein's antimicrobial properties and potential role in disease pathogenesis continue to be areas of active research.

Future research directions may include:

  • Detailed characterization of BD-1's role in specific disease models

  • Development of therapeutic applications based on its antimicrobial properties

  • Investigation of potential synergistic effects with other antimicrobial peptides

  • Exploration of its role in maintaining microbiome homeostasis at epithelial surfaces

Product Specs

Introduction
The Defensin family consists of highly similar antimicrobial and cytotoxic peptides produced by neutrophils. Beta Defensin-1, a member of this family, plays a crucial role in protecting epithelial surfaces from microbial colonization. It exhibits close similarity to Defensin Alpha-1 and has been implicated in the development of cystic fibrosis. Studies have shown that skin affected by atopic dermatitis and mycosis fungoides exhibits reduced expression of human Beta Defensin-1 mRNA but increased expression of human Beta Defensin-2 and -3 mRNA. Notably, epithelial cells are known to express high levels of Beta Defensin. Additionally, Beta-defensin 1 may contribute to the pathogenesis of severe sepsis.
Description
Recombinant Mouse BD 1, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 37 amino acids. With a molecular weight of 4.1 kDa, it is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
Lyophilized from a 0.2µm filtered concentrated solution in phosphate-buffered saline (PBS) at pH 7.4.
Solubility
To reconstitute lyophilized Mouse BD-1, it is recommended to dissolve it in sterile 18 MΩ·cm H₂O at a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions.
Stability
Lyophilized Mouse BD 1 remains stable at room temperature for up to 3 weeks. However, for long-term storage, it is recommended to store it desiccated at a temperature below -18°C. After reconstitution, BD 1 should be stored at 4°C for 2-7 days. For future use, store it below -18°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for extended storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the product exceeds 97.0%, as determined by: (a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis. (b) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Biological Activity
The biological activity is assessed based on the ability to chemoattract CD34+ dendritic cells within a concentration range of 0.1-1.0 µg/ml. This corresponds to a specific activity of 1,000-10,000 units/mg.
Synonyms
Beta-defensin 1, BD-1, Defensin beta 1, hBD-1, HBD1, HBP1, DEFB1, HBD-1, HBP-1, DEFB101, DEFB-1, MGC51822.
Source
Escherichia Coli.
Amino Acid Sequence
DQYKCLQHGG FCLRSSCPSN TKLQGTCKPD KPNCCKS.

Q&A

What ethical considerations should researchers address when designing mouse experiments?

Ethical considerations form the foundation of responsible animal research. When designing mouse experiments, researchers should adhere to the 3Rs principle: Reduction (minimizing animal numbers), Refinement (reducing suffering), and Replacement (using alternatives when possible). Researchers should justify the number of animals needed through power calculations and reduce breeding to only what's necessary for well-designed experiments .

Many institutions require detailed animal use protocols that specify precisely how many mice will be used and for what purpose. Researchers experiencing ethical distress should communicate with supervisors about optimizing colony management to reduce unnecessary animal sacrifice. Some labs conduct regular reviews (e.g., twice yearly) of all mouse lines to determine which can be retired if not needed for immediate experiments .

How can researchers effectively manage mouse colonies for immunological studies?

Effective mouse colony management requires systematic organization and planning. For immunological studies specifically:

  • Maintain detailed breeding records with genotypes and lineage information

  • Implement clear labeling systems for cages and experimental groups

  • Schedule regular health monitoring to prevent disease outbreaks

  • Plan breeding cycles to align with experimental timelines

  • Consider cryopreservation of important lines rather than continuous breeding

For labs managing multiple mouse lines (sometimes dozens), consider implementing a rotation system where certain lines are maintained at minimal breeding levels when not actively needed for experiments. This approach can significantly reduce colony size while maintaining line availability .

What are the basic procedures for preparing mouse tissues for immunological analysis?

Basic tissue preparation for immunological analysis typically follows these methodological steps:

  • Tissue Collection: Harvest relevant tissues (spleen, lymph nodes, blood, etc.) using aseptic technique

  • Single-Cell Suspension: Create single-cell suspensions through mechanical disruption or enzymatic digestion

  • Red Blood Cell Lysis: Treat samples with BD Pharm Lyse™ Lysing Buffer to remove red blood cells

  • Cell Counting: Determine viable cell concentration

  • Surface Staining: Stain with fluorochrome-conjugated antibodies against cell surface markers in the presence of Mouse BD Fc Block™ Reagent and BD Horizon Brilliant Stain Buffer Plus

  • Fixation/Permeabilization: For intracellular markers, fix and permeabilize cells using appropriate reagents like BD Pharmingen Transcription Buffer Set

  • Analysis: Acquire data using flow cytometry instruments such as BD FACSymphony

For adipose tissue specifically, additional collagenase digestion steps are required to properly isolate immune cells from the fat matrix .

How do researchers optimize flow cytometry panels for identifying diverse immune cell populations in mouse tissues?

Optimizing flow cytometry panels for comprehensive immune cell profiling requires strategic panel design:

  • Marker Selection: Choose markers that clearly distinguish target populations (e.g., TCRβ, CD44, CD62L for T cell subsets)

  • Fluorochrome Pairing: Assign brightest fluorochromes to dim or critical markers

  • Spectral Overlap Minimization: Design panels to minimize compensation requirements

  • Titration: Determine optimal antibody concentrations for each marker

  • Controls: Include FMO (Fluorescence Minus One) controls for accurate gating

For advanced applications using instruments like BD FACSymphony A5, researchers can develop high-parameter panels (20+ markers) by leveraging brilliant violet/ultraviolet dyes and careful spectral compensation strategies. This enables simultaneous analysis of multiple immune cell subsets from limited sample volumes .

A systematic validation approach should include testing on both control and experimental samples to ensure panel performance across different conditions (e.g., comparing healthy vs. high-fat diet mice) .

What methodologies are most effective for assessing T cell function in mouse models of metabolic disease?

To comprehensively assess T cell function in metabolic disease models such as diet-induced obesity:

  • Proliferation Assays: Label T cells with CFSE and stimulate with anti-CD3ε and anti-CD28 antibodies to measure division rates

  • Cytokine Production: Use intracellular cytokine staining following PMA/ionomycin stimulation with protein transport inhibitors (BD GolgiPlug™ and BD GolgiStop™)

  • Degranulation Assays: Measure CD107a expression to assess cytotoxic capacity

  • Exhaustion Profiling: Analyze expression of inhibitory receptors like PD-1

  • Metabolic Assays: Measure oxidative phosphorylation and glycolysis using Seahorse analyzers

These methodologies can reveal functional impairments in T cells from metabolic disease models. For example, T cells from adipose tissue of high-fat diet mice often show reduced proliferative capacity and altered cytokine profiles compared to controls .

How can researchers troubleshoot issues with cell viability in mouse tissue processing protocols?

Cell viability issues during mouse tissue processing can severely impact experimental results. A methodological approach to troubleshooting includes:

  • Minimize Processing Time: Keep samples on ice and reduce time between harvest and analysis

  • Optimize Enzyme Concentrations: For tissues requiring enzymatic digestion (e.g., adipose tissue), titrate collagenase concentrations to minimize cell damage

  • Gentler Mechanical Disruption: Use appropriate methods for each tissue type (e.g., gentle filtering for lymphoid tissues)

  • Viability Dye Integration: Always include fixable viability dyes (e.g., FVS620) in staining panels

  • Buffer Optimization: Use protein-containing buffers to maintain cell health

  • Temperature Control: Maintain appropriate temperatures throughout processing

For adipose tissue specifically, researchers should consider using specialized digestion protocols with type II collagenase and shorter incubation times to preserve lymphocyte viability while ensuring adequate tissue dissociation .

What approaches should researchers use to analyze complex flow cytometry data from mouse immunological studies?

Modern immunological studies generate high-dimensional flow cytometry data requiring sophisticated analysis approaches:

  • Manual Gating: Traditional approach using sequential two-dimensional gates

  • Unsupervised Clustering: Algorithms like FlowSOM, PhenoGraph, or SPADE to identify cell populations without bias

  • Dimension Reduction: tSNE or UMAP for visualizing high-parameter data in two dimensions

  • Trajectory Analysis: Algorithms that map developmental relationships between cell populations

  • Statistical Comparison: Methods for comparing population frequencies and marker expression levels between experimental groups

When analyzing complex datasets, such as comparing immune profiles between control diet and high-fat diet mice across multiple tissues, researchers should employ consistent gating strategies across all samples and consider batch effects in analysis .

How do researchers effectively distinguish between naive and memory T cell populations in mouse tissues?

Distinguishing T cell differentiation states requires careful marker selection and gating strategies:

  • Core Markers: CD44 and CD62L expression patterns effectively distinguish naive (CD44-CD62L+), central memory (CD44+CD62L+), and effector memory (CD44+CD62L-) T cells

  • Additional Confirmation Markers: CD127, KLRG1, CD27, and CCR7 can further refine population definitions

  • Tissue-Specific Considerations: Different tissues naturally contain different proportions of these subsets

For example, in normal mouse spleen, naive T cells (CD44-CD62L+) typically comprise approximately 80-85% of CD8+ T cells, while in adipose tissue of mice fed a high-fat diet, effector/memory phenotype (CD44+CD62L-) T cells predominate, comprising over 50% of the T cell compartment .

The distribution of these populations shifts significantly in disease models, with high-fat diet mice showing increased proportions of effector memory phenotype T cells in spleen (30-40% compared to 15-20% in control diet) and even more dramatic shifts in adipose tissue .

What methods are most effective for isolating high-quality viable immune cells from adipose tissue in mouse obesity models?

Isolating immune cells from adipose tissue presents unique challenges requiring specialized protocols:

  • Two-Step Digestion Process:

    • Initial mechanical disruption of adipose tissue

    • Subsequent enzymatic digestion with collagenase II (from suppliers like STEMCELL Technologies)

  • Cell Enrichment:

    • Magnetic separation using CD45.2 antibodies to purify leukocytes

    • Density gradient centrifugation to separate the stromal vascular fraction

  • Quality Control Metrics:

    • Viability assessment with fixable viability dyes

    • Yield per gram of tissue

    • Functional capacity in downstream assays

For optimal results, researchers should process tissue immediately after harvest, maintain consistent digestion times, and include protease inhibitors in buffers when appropriate. Combining adipose tissue from multiple mice of the same experimental group can increase cell yield for comprehensive analysis .

How can researchers address the emotional and ethical challenges associated with extensive mouse work?

Mouse research, particularly involving large colonies or terminal procedures, can cause significant emotional strain. Practical approaches include:

  • Workload Distribution: Distribute animal handling responsibilities among team members to prevent burnout

  • Technical Support: Train and employ dedicated technicians for routine colony management tasks

  • Mental Health Resources: Utilize institutional counseling services specifically for researchers working with animals

  • Regular Breaks: Schedule rotations away from animal work to prevent emotional exhaustion

  • Community Support: Establish peer support groups within research institutions

Some institutions have implemented specific wellness programs for researchers engaged in animal work. These programs acknowledge the emotional toll and provide resources for managing stress and preventing burnout. Researchers should not hesitate to discuss these challenges with supervisors, as solutions often exist that can preserve research progress while addressing researcher wellbeing .

What strategies can optimize breeding efficiency while minimizing unnecessary animal use in immunological research?

Efficient breeding strategies that reduce unnecessary animal use include:

  • Just-in-Time Breeding: Calculate backward from experimental timelines to initiate breeding only when needed

  • Cryopreservation: Freeze embryos or sperm from rarely used lines instead of maintaining live colonies

  • Heterozygous Breeding: When appropriate, maintain lines as heterozygotes to reduce homozygous animals that may not be experimentally useful

  • Colony Oversight Committees: Regular (e.g., biannual) review of all active mouse lines to justify continuation

  • Shared Resources: Coordinate with other researchers to share animals when experiments can be designed collaboratively

These approaches not only address ethical concerns but also improve research efficiency and reduce costs. For example, one laboratory described reducing their mouse colony by approximately 25% through regular line reviews without compromising research progress .

What advanced techniques can researchers use to maximize data obtained from each mouse in immunological studies?

Maximizing data from each animal is both ethically sound and scientifically beneficial. Advanced techniques include:

  • Multi-Organ Analysis: Systematically harvest multiple tissues from each animal for comprehensive immune profiling

  • Sample Banking: Properly preserve unused tissues (flash freezing, RNAlater, etc.) for future analyses

  • Single-Cell Technologies: Implement single-cell RNA sequencing or mass cytometry to extract more information from limited cell numbers

  • In Vivo Imaging: Use techniques like intravital microscopy for longitudinal studies without sacrificing animals

  • Multiplex Assays: Use small-volume multiplex cytokine assays to measure multiple analytes from limited samples

How are researchers integrating multi-omics approaches with traditional flow cytometry in mouse immunology research?

Integrating multi-omics with flow cytometry creates powerful research platforms:

  • Flow Cytometry + Transcriptomics:

    • Flow-sorting specific cell populations for bulk RNA-seq

    • CITE-seq for simultaneous protein and transcript analysis at single-cell level

  • Flow Cytometry + Epigenomics:

    • Sorting cells for ATAC-seq or ChIP-seq

    • Combining histone modification analysis with surface marker profiling

  • Flow Cytometry + Metabolomics:

    • Correlating cellular phenotypes with metabolic profiles

    • Implementing flow cytometry-based metabolic assays

These integrated approaches provide unprecedented insights into immune cell biology. For example, researchers can identify transcriptional programs associated with T cell dysfunction in obesity models, correlating gene expression patterns with surface marker profiles to identify novel therapeutic targets .

What novel mouse models are advancing our understanding of immune dysfunction in metabolic diseases?

Several innovative mouse models are enhancing research into immune-metabolic interactions:

  • Tissue-Specific Knockouts: Cre-lox systems targeting immune genes specifically in adipose, liver, or pancreatic tissues

  • Reporter Lines: Fluorescent protein expression driven by key transcription factors or cytokines

  • Humanized Immune System Mice: NSG mice reconstituted with human immune cells for translational research

  • Inducible Systems: Tet-on/off regulation of gene expression to study temporal aspects of immune dysfunction

  • CRISPR-Modified Models: Precise genetic alterations to study specific pathways

These models enable precise dissection of mechanisms linking obesity to immune dysfunction. For instance, reporter mice expressing fluorescent proteins under control of metabolism-sensitive transcription factors can reveal how nutrient sensing affects immune cell function in real-time .

Product Science Overview

Introduction

BD-1 is an exploration droid that played a significant role in the events following the fall of the Galactic Republic. This droid is known for its companionship with Jedi Master Eno Cordova and later with Cal Kestis, a former Padawan who survived Order 66.

Background and History

BD-1 was designed as an exploration droid, equipped with various tools and features to assist in archaeological and exploratory missions. During the last years of the Galactic Republic, BD-1 accompanied Jedi Master Eno Cordova on his journey to uncover the history of the Zeffo, an ancient civilization. Cordova, realizing the dangers they faced, programmed BD-1’s memory to be blocked, only to be revealed by someone the droid trusted .

Following the rise of the Galactic Empire and the execution of Order 66, BD-1 remained on the planet Bogano, near the Zeffo Vault. It was here that the droid encountered Cal Kestis, a former Padawan who was on a mission to rebuild the fallen Jedi Order. BD-1 quickly formed a bond with Kestis and became an invaluable companion on his journey .

Characteristics and Features

BD-1 is characterized by its small, compact design, making it highly mobile and versatile. The droid is equipped with a variety of tools, including a spotlight, scomp link, holoprojector, stim canister storage, and electro darts. These features make BD-1 an essential companion for exploration and combat situations .

Role in “Star Wars Jedi: Fallen Order”

In the game “Star Wars Jedi: Fallen Order,” BD-1 plays a crucial role in assisting Cal Kestis on his quest to uncover the secrets of the Zeffo and rebuild the Jedi Order. The droid’s ability to scan artifacts, provide healing stim canisters, and access locked areas through its scomp link proves invaluable throughout the journey. BD-1’s loyalty and resourcefulness make it a beloved character among fans of the game .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.